Mechanistic studies in oocyte donors can inform reproductive biology while leaving treatment effectiveness in infertile patients unresolved. Primary report
Study snapshot
The randomized trial compared highly purified hMG with recombinant FSH in 112 oocyte donors. It measured serum hormones during stimulation and hormones in follicular fluid. Serum progesterone was lower with hMG near the end of stimulation, while the pattern was not identical in follicular fluid. The investigators emphasized that participants were young, noninfertile women with good ovarian reserve. Primary report
Our appraisal: keep compartment and population attached
The same named hormone can have different measurements in blood and follicular fluid. Those findings should not be collapsed into one statement that an intervention universally lowers or raises the hormone. Sampling time and biological compartment are part of the endpoint.
A proposed steroidogenic pathway also needs careful wording. Measured concentrations and ratios can support a mechanistic interpretation, but they are not automatically direct measurements of every biochemical conversion rate. The strength of that interpretation depends on the actual assay and design.
The donor population limits clinical extrapolation. A hormone pattern in selected donors does not establish improved pregnancy or live birth in patients with reduced reserve, different ages, or other infertility diagnoses. Even a plausible explanation for an earlier clinical observation remains distinct from testing that clinical outcome directly.
Full review should examine serial sampling, assay characteristics, multiple comparisons, and the relationship between ovarian response and the reported hormone differences. The useful contribution is a more specific biological hypothesis, not a blanket ranking of fertility medicines.
Frequently asked questions
Were the participants infertile patients?
No. They were selected oocyte donors.
Were both serum and follicular fluid studied?
Yes.
Did every compartment show the same progesterone result?
No. Preserve the compartment-specific findings.
Does a hormone ratio directly prove pathway flux?
Not without an appropriate measurement and analysis.
Can the study establish higher live-birth rates?
Not from the reported mechanistic measurements alone.
Why does ovarian reserve matter to interpretation?
It is part of the population definition and possible treatment-response context.
What remains pending?
Full assay, serial-analysis, multiplicity, and applicability review.